From: Clinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma
Variables | MFN2 expression | Â | |
---|---|---|---|
Low | High | P value | |
n = 58 | n = 57 | ||
Age (year) | 57.1 ± 11.4 | 57.1 ± 9.9 | 0.996 |
Gender (female/male) | 3/55 | 12/45 | 0.012 |
HBsAg (no/yes) | 15/43 | 7/50 | 0.065 |
HBV-DNA replication (no/yes) | 34/24 | 32/25 | 0.789 |
Liver cirrhosis (no/yes) | 22/36 | 18/39 | 0.476 |
Preoperative AFP | 6292.3 ± 14073.3 | 4075.1 ± 13793.9 | 0.048 |
Tumor number (1/>1) | 44/14 | 42/15 | 0.789 |
Tumor size (cm) | 6.9 ± 3.6 | 6.3 ± 3.0 | 0.610 |
PV or VI invasion (no/yes) | 37/21 | 43/14 | 0.177 |
Lymph node metastasis (no/yes) | 51/7 | 47/10 | 0.410 |
Intrahepatic metastasis (no/yes) | 38/20 | 33/24 | 0.402 |
Liver capsular invasion (no/yes) | 40/18 | 41/16 | 0.729 |
TNM stage (I/II–IV) | 23/35 | 22/35 | 0.908 |
Differentiation (well/moderate or poor) | 20/38 | 28/29 | 0.113 |